Afinitor (Everolimus) Approved For Renal Angiomyolipomas By FDA
Afinitor (everolimus) has been approved by the FDA for renal angiomyolipomas (non-cancerous Kidney Tumors) that do not require urgent surgery in patients with TSC (Tuberous Sclerosis Complex). Tuberous sclerosis complex is a very rare genetic condition in which non-cancerous tumors grow in the brain, kidney, skin, heart and other Vital Organs. It is estimated that about 40,000 people in the USA are affected by TSC. Between 70% and 80% of those with TSC go on to develop kidney problems. Typically, a patient with TSC develops several tumors in both kidneys... read more..
source:http://bit.ly/J7qqGI
No comments:
Post a Comment